Sen. Sanders: Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic, Wegovy
September 17, 2024
September 17, 2024
WASHINGTON, Sept. 17 -- Sen. Bernie Sanders, I-Vermont, issued the following news release:
Ahead of next week's hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor and Pensions (HELP), announced today that more than 250 clinicians from across the country are asking Congress to rein in exorbitant prices fo . . .
Ahead of next week's hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor and Pensions (HELP), announced today that more than 250 clinicians from across the country are asking Congress to rein in exorbitant prices fo . . .